Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | CDK1 | P06493 | 1/20 | 0.52 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.52 |
| ▸ | ENGASE | Q8NFI3 | 1/20 | 0.50 |
| ▸ | ACHE | P22303 | 1/20 | 0.49 |
| ▸ | CD209 | Q9NNX6 | 2/20 | 0.47 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.47 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.47 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.47 |
| ▸ | SYNJ2 | O15056 | 2/20 | 0.46 |
| ▸ | AMY2A | P04746 | 2/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19402661 | 1.00 | MEN1 (0.54) | MEN1KMT2ACDK1CCNB1ENGASE | |
| SCHEMBL20000766 | 0.92 | MEN1 (0.62) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| SCHEMBL25769261 | 0.90 | MEN1 (0.59) | MEN1KMT2AENGASELGALS8LGALS3 | |
| SCHEMBL12990077 | 0.85 | MEN1 (0.53) | MEN1KMT2ACDK1CCNB1ENGASE | |
| SCHEMBL23571346 | 0.82 | MEN1 (0.56) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| SCHEMBL14506914 | 0.81 | LGALS3 (0.63) | MEN1KMT2ACDK1CCNB1ENGASE | |
| SCHEMBL11265985 | 0.81 | LGALS3 (0.63) | MEN1KMT2ACDK1CCNB1ENGASE | |
| SCHEMBL12990264 | 0.81 | CD209 (0.64) | MEN1KMT2ACDK1CCNB1ENGASE | |
| SCHEMBL29777515 | 0.81 | CD209 (0.64) | MEN1KMT2ACDK1CCNB1ENGASE | |
| SCHEMBL12989798 | 0.81 | CD209 (0.64) | MEN1KMT2ACDK1CCNB1ENGASE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180206518-A1 | METHOD OF MAKING CANNABIS OIL HYDROPHILIC USING EMULSIFIERS AND RELATED CANNABINOID COMPOSITIONS | SRE WELLNESS, INC. | 2018-07-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180206518-A1 | METHOD OF MAKING CANNABIS OIL HYDROPHILIC USING EMULSIFIERS AND RELATED CANNABINOID COMPOSITIONS | CNR2, CNR1, FAAH | MEN1 4051/4885KMT2A 3464/4885CDK1 2325/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.